GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation ...
Chronic heart ... challenging. Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which ...
Concurrently, the number of short-acting nitrate tablets taken per week decreased ... increased from 62.3 ± 0.7 to 77.4 ± 0.5, and disease perception improved from 36.7 ± 0.6 to 55.5 ± 0.7 ...
Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...
You may not need to take drugs to bring blood pressure down. Do you have high blood pressure? You most likely do without even knowing it. In a new report, 48% of U.S. adults have high blood ...
Zyn has nicotine, which is addictive and increases heart rate. The pouches are not safer than cigarettes or vapes. Learn ...
"The results of the study are consistent with other research about the preventive role of these medications against cardiovascular disease in people with obesity or heart failure," Sheffeh said.
Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.
Nov. 11, 2024 — Fear of another heart attack was a significant ongoing contributor to how heart attack survivors perceive their health, according to a study. While anxiety and depression are ...
Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...
At the American Heart Association ... artery disease and moderately decreased left ventricular ejection fraction (LVEF), indicating heart failure. Seven of the patients received the drug during ...